Alphatec ( NASDAQ:ATEC – Get Rating ) had its price objective hoisted by Morgan Stanley from $17.00 to $18.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have an overweight rating on the medical technology company's stock. ATEC has been the topic of several other research reports. Needham & Company LLC lifted their target price on shares of Alphatec from $13.00 to $14.00 and gave the company a buy rating in a report on Friday, November 4th. Lake Street Capital lifted their price target on shares of Alphatec from $16.

https://www.dailypolitical.com/2023/03/05/alphatec-nasdaqatec-pt-raised-to-18-00-at-morgan-stanley.html

#dailypolitical